Risk factors for QTc interval prolongation.
Heemskerk CPM, Pereboom M, van Stralen K, Berger FA, van den Bemt PMLA, Kuijper AFM, van der Hoeven RTM, Mantel-Teeuwisse AK, Becker ML.
Heemskerk CPM, et al.
Eur J Clin Pharmacol. 2018 Feb;74(2):183-191. doi: 10.1007/s00228-017-2381-5. Epub 2017 Nov 22.
Eur J Clin Pharmacol. 2018.
PMID: 29167918